This Week Last Year in Medtech: May 7-13
2023-05-11
并购
Is Magneto the Hero We Need to Destroy Blood Clots?
Unlike the Marvel Universe character by the same name, this Magneto is battling blood clots with a device based on electric fields.
This Company Is Reinventing the Heart Valve
Foldax is trying to eliminate the tradeoff between mechanical and tissue heart valves by starting from scratch.
Medtronic Hits an FTC Roadblock in Intersect ENT Deal
The Federal Trade Commission wants Medtronic to divest an Intersect ENT subsidiary as a condition of the deal.
Bioventus Needs to Find Another Way to Pay for CartiHeal
The company has nixed a $415 sale of senior notes that was meant to fund its acquisition of CartiHeal.
Can Globus Turn Things Around in a Competitive Spine Market?
The company will need to rebound in the second quarter to earn back investor confidence.
Could HF be Diagnosed with Just an MRI?
Researchers found that MRI could be a reliable and safe option all while avoiding an invasive procedure.
Would You Take a Poop Pill?
Fecal transplants have been proven effective at treating C. diff, but current delivery methods are lacking. Is stool encapsulation the answer?
Medtronic Wins FDA Nod for Onyx Frontier DES
The Dublin-based company said the device is the latest innovation in the Resolute DES family.
Most Anticipated New Medical Devices in 2022
These medical devices are expected to hit the U.S. market in 2022.
Elekta's Esprit Will Enable More Personalized Radio-surgery
Elekta’s new radiosurgery system, Esprit, features sub-millimeter accuracy and allows treatment planning in less than 60 seconds.
How Nufabrx Is Changing the Medical Landscape
What if your medications could be delivered by your clothing?
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
靶点
-药物
-热门报告
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。